company background image
IART logo

Integra LifeSciences Holdings NasdaqGS:IART 株式レポート

最終価格

US$23.58

時価総額

US$1.8b

7D

3.1%

1Y

-40.4%

更新

22 Nov, 2024

データ

会社財務 +

Integra LifeSciences Holdings Corporation

NasdaqGS:IART 株式レポート

時価総額:US$1.8b

IART 株式概要

インテグラ・ライフサイエンス・ホールディングス・コーポレーションは、脳神経外科、神経クリティカルケア、耳鼻咽喉科で使用される手術器具、神経外科製品、創傷ケア製品を製造・販売している。 詳細

IART ファンダメンタル分析
スノーフレーク・スコア
評価5/6
将来の成長3/6
過去の実績0/6
財務の健全性2/6
配当金0/6

Integra LifeSciences Holdings Corporation 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめIntegra LifeSciences Holdings
過去の株価
現在の株価US$23.58
52週高値US$45.42
52週安値US$16.81
ベータ1.08
11ヶ月の変化23.39%
3ヶ月変化11.91%
1年変化-40.38%
33年間の変化-63.64%
5年間の変化-61.34%
IPOからの変化409.84%

最新ニュース

There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise

Nov 05
There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise

Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Oct 24
Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Recent updates

There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise

Nov 05
There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise

Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Oct 24
Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S

Sep 08
Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S

Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?

Aug 21
Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?

At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?

Jul 01
At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?

Integra LifeSciences Still Underperforming As Manufacturing Issues Linger

Jun 21

Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price

May 28
Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price

Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled

Feb 27
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled

We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Feb 11
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Jan 14
Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings

Dec 31
Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings

Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?

Dec 03
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?

Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?

Nov 06
Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?

Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns

Oct 24
Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns

Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Sep 22
Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?

Aug 15
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?

Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes

Jul 03
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes

Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Jun 19
Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

May 05
Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well

Apr 07
These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well

Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital

Mar 26
Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital

At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?

Mar 14
At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?

Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?

Feb 27
Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?

Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Feb 02
Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Jan 05
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return

Dec 21
Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return

When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Dec 08
When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

株主還元

IARTUS Medical EquipmentUS 市場
7D3.1%1.5%2.2%
1Y-40.4%20.9%31.7%

業界別リターン: IART過去 1 年間で20.9 % の収益を上げたUS Medical Equipment業界を下回りました。

リターン対市場: IARTは、過去 1 年間で31.7 % のリターンを上げたUS市場を下回りました。

価格変動

Is IART's price volatile compared to industry and market?
IART volatility
IART Average Weekly Movement9.0%
Medical Equipment Industry Average Movement8.1%
Market Average Movement6.3%
10% most volatile stocks in US Market15.8%
10% least volatile stocks in US Market3.1%

安定した株価: IART過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: IARTの 週次ボラティリティ ( 9% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
19893,946Jan De Wittewww.integralife.com

インテグラ・ライフサイエンス・ホールディングス・コーポレーションは、脳神経外科、神経クリティカルケア、耳鼻咽喉科で使用される手術器具、神経外科製品、創傷ケア製品を製造・販売している。Codman Specialty SurgicalとTissue Technologiesの2つのセグメントで事業を展開。同社は、組織切除装置、硬膜修復製品、脳脊髄液管理装置、頭蓋内モニタリング装置、頭蓋安定化装置などの脳神経外科および神経クリティカルケア製品、手術用ヘッドランプおよび器具、アフターマーケットサービスを提供している。また、病院や手術センター、歯科医院、足病医院、動物病院向けに器具パターン、手術用製品、照明製品を販売している。さらに、急性創傷治療のための再生技術製品や、ヘルニア、腱、末梢神経修復・保護のための外科組織修復製品も提供している。さらに、皮膚や創傷の修復、プラスチックや外科的再建製品、骨移植片、神経や腱の修復製品も提供している。同社は、様々な販売部隊やその他の流通チャネルを通じて、米国、欧州、アジア太平洋地域、および国際的な病院、統合医療ネットワーク、グループ購買組織、臨床医、手術センター、医療提供者に直接製品を提供している。インテグラ・ライフサイエンス・ホールディングス・コーポレーションは1989年に設立され、ニュージャージー州プリンストンに本社を置いている。

Integra LifeSciences Holdings Corporation 基礎のまとめ

Integra LifeSciences Holdings の収益と売上を時価総額と比較するとどうか。
IART 基礎統計学
時価総額US$1.77b
収益(TTM)-US$6.54m
売上高(TTM)US$1.56b

1.2x

P/Sレシオ

-278.0x

PER(株価収益率

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
IART 損益計算書(TTM)
収益US$1.56b
売上原価US$632.40m
売上総利益US$932.52m
その他の費用US$939.06m
収益-US$6.54m

直近の収益報告

Sep 30, 2024

次回決算日

該当なし

一株当たり利益(EPS)-0.085
グロス・マージン59.59%
純利益率-0.42%
有利子負債/自己資本比率118.9%

IART の長期的なパフォーマンスは?

過去の実績と比較を見る